These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1559308)

  • 1. Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling.
    Williams PJ; Lane J; Murray W; Mergener MA; Kamigaki M
    Clin Pharmacokinet; 1992 Jan; 22(1):66-74. PubMed ID: 1559308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations.
    Bauer LA; Horn JR; Pettit H
    Ther Drug Monit; 1996 Feb; 18(1):46-52. PubMed ID: 8848820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling.
    Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M
    Drugs Aging; 2011 Oct; 28(10):831-41. PubMed ID: 21970310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of three methods for predicting digoxin concentrations.
    Williams PJ; Lane JR; Capparelli EV; Kim YH; Coleman R
    Pharmacotherapy; 1996; 16(6):1085-92. PubMed ID: 8947982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications.
    Doering W
    N Engl J Med; 1979 Aug; 301(8):400-4. PubMed ID: 460341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.
    Yukawa E; Suematu F; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y; Aoyama T
    Clin Pharmacokinet; 2001; 40(10):773-81. PubMed ID: 11707062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin-quinidine interaction Pharmacokinetic evaluation.
    Hager WD; Fenster P; Mayersohn M; Perrier D; Graves P; Marcus FI; Goldman S
    N Engl J Med; 1979 May; 300(22):1238-41. PubMed ID: 431681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
    Yukawa E; Mine H; Higuchi S; Aoyama T
    J Pharm Pharmacol; 1992 Sep; 44(9):761-5. PubMed ID: 1360530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice.
    Zhou XD; Gao Y; Guan Z; Li ZD; Li J
    Acta Pharmacol Sin; 2010 Jun; 31(6):753-8. PubMed ID: 20523346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of ibopamine on different diseases and conditions.
    Ventresca GP; Lodola E
    Arzneimittelforschung; 1988 Aug; 38(8):1175-80. PubMed ID: 2904270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic investigation of digoxin in Japanese neonates.
    Yukawa E; Akiyama K; Suematsu F; Yukawa M; Minemoto M
    J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered absorption of digoxin, sustained-release quinidine, and warfarin with sucralfate administration.
    Rey AM; Gums JG
    DICP; 1991; 25(7-8):745-6. PubMed ID: 1949932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of digoxin in Thai pediatric patients.
    Preechagoon Y; Somsaard P; Petcharattana S
    J Med Assoc Thai; 2009 Oct; 92(10):1324-35. PubMed ID: 19845241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of quinidine.
    Fattinger K; Vozeh S; Ha HR; Borner M; Follath F
    Br J Clin Pharmacol; 1991 Mar; 31(3):279-86. PubMed ID: 2054269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.
    Yukawa E; Honda T; Ohdo S; Higuchi S; Aoyama T
    J Clin Pharmacol; 1997 Feb; 37(2):92-100. PubMed ID: 9055134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense?
    el-Desoky ES; Madabushi R; Amry Sel-D; Bhattaram VA; Derendorf H
    Am J Ther; 2005; 12(4):320-7. PubMed ID: 16041195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction of digoxin and quinidine].
    Haustein KO; Oltmanns G
    Z Gesamte Inn Med; 1980 Feb; 35(4):186-7. PubMed ID: 7405308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction.
    Schenck-Gustafsson K; Dahlqvist R
    Br J Clin Pharmacol; 1981 Feb; 11(2):181-6. PubMed ID: 7213521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of digoxin clearance by coadministration of quinidine.
    Ochs HR; Bodem G; Greenblatt DJ
    J Clin Pharmacol; 1981 Oct; 21(10):396-400. PubMed ID: 7309901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.